← Ekachai Medical Care overview

Ekachai Medical Care vs Universal Health Services: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Ekachai Medical Care Public Company Limited (EKH.BK)

Q3 2026
▲4

EKH expands specialty hospitals as Q2 profit jumps 28%

  • Q2 profit surges 28% on higher patient volumes EKH's Q2 2026 net profit rose 27.88% to 60.18 million baht, with revenue up 22.35% to 342.88 million baht. Growth came from more patients at Khun Hospital Rama 2, the heart center, and the IVF fertility unit, helped by returning Chinese clients. This shows the core business is healthy and supports the stock price.

    This is the key earnings result that shows EKH's core business is growing strongly.

  • New specialty hospitals to drive future revenue EKH is building three new projects: Khun Wattanapat (elderly care), Bloom Hospital (mental health), and a wellness center. Bloom opened in September with 400 million baht invested, targeting 50 million baht first-year revenue. These expand EKH's revenue base and support long-term growth, pushing the stock up.

    These new projects are the main growth drivers that will add revenue from Q3 2026 onward.

  • Q3 patient volumes rise on seasonal outbreaks EKH reported Q3 2026 patient numbers grew, with bed occupancy at 50-70%, helped by COVID-19 and flu outbreaks and volatile weather. The company expects second-half results to beat the first half and maintains double-digit full-year revenue growth. This supports the stock price.

    This shows the positive trend continuing into Q3, confirming the growth story.

  • Brokerage sets 5.85 baht target, sees recovery Yuanta Securities maintained a Trading recommendation with a 5.85 baht target after visiting Bloom Hospital. It expects 2026 profit of 248 million baht and dividend yields of 5.5-6.1%, with a clear recovery in 2027. This gives investors confidence and can lift the stock.

    Analyst coverage with a target price and dividend yield provides a valuation anchor for investors.

September 2026
▲4

EKH expands specialty hospitals as Q2 profit jumps 28%

  • Q2 profit surges 28% on higher patient volumes EKH's Q2 2026 net profit rose 27.88% to 60.18 million baht, with revenue up 22.35% to 342.88 million baht. Growth came from more patients at Khun Hospital Rama 2, the heart center, and the IVF fertility unit, helped by returning Chinese clients. This shows the core business is healthy and supports the stock price.

    This is the key earnings result that shows EKH's core business is growing strongly.

  • New specialty hospitals to drive future revenue EKH is building three new projects: Khun Wattanapat (elderly care), Bloom Hospital (mental health), and a wellness center. Bloom opened in September with 400 million baht invested, targeting 50 million baht first-year revenue. These expand EKH's revenue base and support long-term growth, pushing the stock up.

    These new projects are the main growth drivers that will add revenue from Q3 2026 onward.

  • Q3 patient volumes rise on seasonal outbreaks EKH reported Q3 2026 patient numbers grew, with bed occupancy at 50-70%, helped by COVID-19 and flu outbreaks and volatile weather. The company expects second-half results to beat the first half and maintains double-digit full-year revenue growth. This supports the stock price.

    This shows the positive trend continuing into Q3, confirming the growth story.

  • Brokerage sets 5.85 baht target, sees recovery Yuanta Securities maintained a Trading recommendation with a 5.85 baht target after visiting Bloom Hospital. It expects 2026 profit of 248 million baht and dividend yields of 5.5-6.1%, with a clear recovery in 2027. This gives investors confidence and can lift the stock.

    Analyst coverage with a target price and dividend yield provides a valuation anchor for investors.

Latest
▲4

EKH expands specialty hospitals as Q2 profit jumps 28%

  • Q2 profit surges 28% on higher patient volumes EKH's Q2 2026 net profit rose 27.88% to 60.18 million baht, with revenue up 22.35% to 342.88 million baht. Growth came from more patients at Khun Hospital Rama 2, the heart center, and the IVF fertility unit, helped by returning Chinese clients. This shows the core business is healthy and supports the stock price.

    This is the key earnings result that shows EKH's core business is growing strongly.

  • New specialty hospitals to drive future revenue EKH is building three new projects: Khun Wattanapat (elderly care), Bloom Hospital (mental health), and a wellness center. Bloom opened in September with 400 million baht invested, targeting 50 million baht first-year revenue. These expand EKH's revenue base and support long-term growth, pushing the stock up.

    These new projects are the main growth drivers that will add revenue from Q3 2026 onward.

  • Q3 patient volumes rise on seasonal outbreaks EKH reported Q3 2026 patient numbers grew, with bed occupancy at 50-70%, helped by COVID-19 and flu outbreaks and volatile weather. The company expects second-half results to beat the first half and maintains double-digit full-year revenue growth. This supports the stock price.

    This shows the positive trend continuing into Q3, confirming the growth story.

  • Brokerage sets 5.85 baht target, sees recovery Yuanta Securities maintained a Trading recommendation with a 5.85 baht target after visiting Bloom Hospital. It expects 2026 profit of 248 million baht and dividend yields of 5.5-6.1%, with a clear recovery in 2027. This gives investors confidence and can lift the stock.

    Analyst coverage with a target price and dividend yield provides a valuation anchor for investors.

Universal Health Services Inc (UHS)

Q3 2026
▲2▼2

UHS: AI Edge and Talkspace Deal Offset by Labor Costs and Guidance Cut

  • AI Coding Platform Margin Edge UHS's AI coding platform generates about $50 million annually, which could give it a lasting cost advantage over nonprofit hospital rivals and support profit margins.

    This new technology-driven advantage is a key positive force for UHS's profitability and stock.

  • Talkspace Acquisition to Boost EPS The $835 million purchase of Talkspace adds 6,000 therapists and is expected to increase earnings per share, expanding UHS's behavioral health services.

    This major acquisition is a new growth driver that could lift UHS's earnings and stock price.

  • Nursing Shortage Raises Labor Costs The nursing shortage worsened from 28% to 39%, driving up labor expenses. Operating costs rose 9%, pressuring margins despite revenue growth.

    This escalating cost issue directly threatens UHS's profitability and is a major negative force.

  • Guidance Cut After Q2 Miss UHS lowered its full-year EPS and EBITDA guidance after missing second-quarter estimates, signaling weaker-than-expected financial performance and future uncertainty.

    The guidance cut is a clear negative signal that likely weighed on investor sentiment and the stock price.

August 2026
▲2▼1

UHS earnings miss and guidance cut, offset by Talkspace deal and buyback

  • Q2 earnings miss and lowered full-year guidance UHS missed second-quarter EPS estimates and cut its full-year adjusted earnings guidance to $22.28-$23.65 from a prior range. The company was the only healthcare firm to miss EPS that week. Lower profit expectations weigh on the stock because investors pay less for each dollar of future earnings.

    This is the main negative force this period, directly explaining the initial sharp stock drop.

  • Talkspace acquisition completed, expected to boost EPS UHS closed its $835 million all-cash purchase of virtual therapy provider Talkspace, adding 6,000 licensed therapists and access to over 200 million people through health plans and employers. Management expects the deal to slightly increase adjusted EPS within a year, expanding UHS's behavioral health reach.

    This is a new, concrete growth move that supports the stock by expanding UHS's digital behavioral health business.

  • Buyback completed and stock seen as undervalued UHS finished its long-running share repurchase program, and the stock trades well below a widely followed fair-value estimate of $205.24. Fewer shares outstanding can lift earnings per share, and the discount may attract value-focused investors. Risks remain from Medicaid policy changes and workforce shortages.

    This explains a positive capital-return and valuation angle that supports the stock despite the earnings miss.

  • Revenue beat and raised revenue guidance, but profit outlook cut UHS beat second-quarter revenue estimates and raised its full-year revenue guidance, yet lowered its EBITDA and EPS forecasts. The stock has gained 5.7% since the report, but analyst profit estimates have fallen over the past month. Revenue growth is solid, but margins are under pressure.

    This captures the mixed picture: top-line strength versus bottom-line caution, which is the core tension for the stock now.

Latest
▲2▼1

UHS earnings miss and guidance cut, offset by Talkspace deal and buyback

  • Q2 earnings miss and lowered full-year guidance UHS missed second-quarter EPS estimates and cut its full-year adjusted earnings guidance to $22.28-$23.65 from a prior range. The company was the only healthcare firm to miss EPS that week. Lower profit expectations weigh on the stock because investors pay less for each dollar of future earnings.

    This is the main negative force this period, directly explaining the initial sharp stock drop.

  • Talkspace acquisition completed, expected to boost EPS UHS closed its $835 million all-cash purchase of virtual therapy provider Talkspace, adding 6,000 licensed therapists and access to over 200 million people through health plans and employers. Management expects the deal to slightly increase adjusted EPS within a year, expanding UHS's behavioral health reach.

    This is a new, concrete growth move that supports the stock by expanding UHS's digital behavioral health business.

  • Buyback completed and stock seen as undervalued UHS finished its long-running share repurchase program, and the stock trades well below a widely followed fair-value estimate of $205.24. Fewer shares outstanding can lift earnings per share, and the discount may attract value-focused investors. Risks remain from Medicaid policy changes and workforce shortages.

    This explains a positive capital-return and valuation angle that supports the stock despite the earnings miss.

  • Revenue beat and raised revenue guidance, but profit outlook cut UHS beat second-quarter revenue estimates and raised its full-year revenue guidance, yet lowered its EBITDA and EPS forecasts. The stock has gained 5.7% since the report, but analyst profit estimates have fallen over the past month. Revenue growth is solid, but margins are under pressure.

    This captures the mixed picture: top-line strength versus bottom-line caution, which is the core tension for the stock now.

July 2026
▲1▼1

UHS swings on AI upside, labor shortages, and mixed earnings

  • AI coding platform adds $50M annualized revenue UBS says hospitals may gain more from AI than insurers, noting UHS already earns about $50 million a year from an AI coding platform. This supports profit margins and gives UHS a multiyear edge over slower nonprofit rivals, pushing the stock up.

    Shows a new, concrete technology-driven revenue and margin driver for UHS.

  • Nursing shortage worsens, raising labor costs The nursing shortage rate jumped from 28% to 39%, and peer HCA cut its profit outlook. For UHS, this means higher wages and tighter margins, a real headwind that pushed shares down 5.6% on the day and keeps pressure on the stock.

    Identifies a key supply-side cost pressure that directly hurts UHS profitability.

  • Q2 profit rises but guidance cut on higher costs UHS reported higher Q2 net income of $358.4 million and 8.3% revenue growth, but then cut full-year EPS guidance and missed Q2 expectations as operating expenses rose 9%. The strong quarter is offset by cost worries, leaving the stock down on the guidance cut.

    Captures the latest earnings result and the guidance cut that moved the stock.

▲1▼1

UHS swings on AI upside, labor shortages, and mixed earnings

  • AI coding platform adds $50M annualized revenue UBS says hospitals may gain more from AI than insurers, noting UHS already earns about $50 million a year from an AI coding platform. This supports profit margins and gives UHS a multiyear edge over slower nonprofit rivals, pushing the stock up.

    Shows a new, concrete technology-driven revenue and margin driver for UHS.

  • Nursing shortage worsens, raising labor costs The nursing shortage rate jumped from 28% to 39%, and peer HCA cut its profit outlook. For UHS, this means higher wages and tighter margins, a real headwind that pushed shares down 5.6% on the day and keeps pressure on the stock.

    Identifies a key supply-side cost pressure that directly hurts UHS profitability.

  • Q2 profit rises but guidance cut on higher costs UHS reported higher Q2 net income of $358.4 million and 8.3% revenue growth, but then cut full-year EPS guidance and missed Q2 expectations as operating expenses rose 9%. The strong quarter is offset by cost worries, leaving the stock down on the guidance cut.

    Captures the latest earnings result and the guidance cut that moved the stock.